Chinook Therapeutics Inc – Plans of Reorganization, Merger, Acquisition or Similar – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 96 pages Agreement and Plan of Merger Dated as of June 11, 2023, Among Novartis AG, Cherry Merger Sub Inc. and Chinook Therapeutics, Inc

from 8-K 7 pages Amendment No. 1 to Agreement and Plan of Merger and Reorganization

from 425 90 pages Agreement and Plan of Merger and Reorganization Among: Aduro Biotech, Inc., a Delaware Corporation; Aspire Merger Sub, Inc., a Delaware Corporation; and Chinook Therapeutics U.S., Inc., a Delaware Corporation Dated as of June 1, 2020

from 8-K 90 pages Agreement and Plan of Merger and Reorganization Among: Aduro Biotech, Inc., a Delaware Corporation; Aspire Merger Sub, Inc., a Delaware Corporation; and Chinook Therapeutics U.S., Inc., a Delaware Corporation Dated as of June 1, 2020

from 10-Q 47 pages Share Sale Agreement Dated 24 September 2015 Between Brabant Life Sciences Seed Fonds B.V. Spin-Off Fonds Brabant B.V. Bff B.V. as the Sellers and Aduro Biotech, Inc. as the Purchaser and Aduro Netherlands Coöperatief U.A. as the Acquiring Party and Bionovion Holding B.V. as the Company for the Sale by the Sellers of the Entire Issued Share Capital of the Company